Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SINGULARITY: AI-Guided Treatment Selection in Solid Tumors
NCT06824792Phase 4Not yet recruiting
- Start
- Mar 2025
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in solid tumor (advanced stage). Primary endpoint: Progression-free survival up to 2 years. Planned start Mar 2025; status: not yet recruiting.
02
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT06824792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06824792.